This inventor holds 7 USPTO granted patents and 11 published patent applications, plus 6 CIPO patents and 9 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2013-2021.
Company Filing History:
Years Active: 2013-2021
Title: Guenter Moddelmog: Innovator in Pharmaceutical Patents
Introduction
Guenter Moddelmog is a notable inventor based in Reinheim, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on innovative solutions that enhance the effectiveness and usability of pharmaceutical products.
Latest Patents
Among his latest patents is the invention of glycine particles. This invention relates to compacted glycine granules, where at least 75% of the granules have a particle size of above 0.7 mm. It also includes a process for the preparation and use of these granules. Another significant patent is for a direct injection moldable and rapidly disintegrating tablet matrix. This invention pertains to a novel directly compressible matrix for the production of tablets that disintegrate rapidly in the presence of moisture, particularly in the mouth.
Career Highlights
Guenter Moddelmog is currently associated with Merck Patent GmbH, where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to advancements that benefit both manufacturers and consumers.
Collaborations
Some of his notable coworkers include Thorsten Wedel and Roberto Ognibene. Their collaborative efforts contribute to the innovative environment at Merck Patent GmbH.
Conclusion
Guenter Moddelmog's contributions to pharmaceutical patents demonstrate his commitment to innovation and improvement in the industry. His inventions, particularly in glycine granules and rapidly disintegrating tablet matrices, highlight his role as a key figure in pharmaceutical advancements.